Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juin Hsien Chai"'
Autor:
Dominic Chih-Cheng Voon, Huajing Wang, Jason Kin Wai Koo, Juin Hsien Chai, Yit Teng Hor, Tuan Zea Tan, Yeh-Shiu Chu, Seiichi Mori, Yoshiaki Ito
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70427 (2013)
Recent studies have revealed that differentiated epithelial cells would acquire stem cell-like and tumorigenic properties following an Epithelial-Mesenchymal Transition (EMT). However, the signaling pathways that participate in this novel mechanism o
Externí odkaz:
https://doaj.org/article/02cb0950139e4fabaef59917a9bed864
Autor:
Seiichi Mori, Yeh Shiu Chu, Huajing Wang, Dominic Chih-Cheng Voon, Juin Hsien Chai, Yoshiaki Ito, Jason Kin Wai Koo, Tuan Zea Tan, Yit Teng Hor
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70427 (2013)
PLoS ONE
PLoS ONE
Recent studies have revealed that differentiated epithelial cells would acquire stem cell-like and tumorigenic properties following an Epithelial-Mesenchymal Transition (EMT). However, the signaling pathways that participate in this novel mechanism o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c053f3e348ff4efb1356ceb3928e19
http://europepmc.org/articles/PMC3741305?pdf=render
http://europepmc.org/articles/PMC3741305?pdf=render
Publikováno v:
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 512 (2011)
BMC Cancer, Vol 11, Iss 1, p 512 (2011)
Background The cytogenetic characteristic of Chronic Myeloid Leukemia (CML) is the formation of the Philadelphia chromosome gene product, BCR-ABL. Given that BCR-ABL is the specific target of Gleevec in CML treatment, we investigated the regulation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63542e56f5e12c54441c46991e793fd1
http://europepmc.org/articles/PMC3259104
http://europepmc.org/articles/PMC3259104